Formulary guidance and transparency from P&T to point of care

Trends That Matter for Chronic Heart Failure

Posted by Matt Breese on Nov 16, 2017

Find me on:


Heart failure is one of the most common causes of patient hospitalization in the U.S. However, the mechanisms behind this are not fully understood in the medical field. 

For providers treating patients with chronic heart failure, new technology could drastically improve the success of treatment. UCLA researchers have created a virtual model that can test pharmaceuticals based on patient scenarios to prevent adverse events.

How will this "virtual heart" impact the pharma industry? According to Matthew Chin, contributor to the UCLA Newsroom:
"The invention could help doctors zero in on effective new drug therapies for heart failure because it should make it easier to understand how certain medications work, and when and where in the heart they can be most effective."

To learn more about this topic, download MMIT's Reality Check on Chronic Heart Failure by clicking on the button below: 

View Reality Check

Topics: Specialty, Market Access